• Sunday, October 02, 2022

Business

Novartis scraps sale of assets including COVID-19 hopeful to India’s Aurobindo

NOVARTIS AG on Thursday (2) scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India’s Aurobindo Pharma Ltd as regulators balked, setting back the Swiss…